Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
2.610
+0.005 (0.19%)
Nov 13, 2026, 4:00 PM EST - Market closed
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.92 million as of November 13, 2026. It is the 46,830th most valuable company in the world and the 6,202nd biggest in the United States. Its market cap has decreased by 0.80% in one year.
Market Cap
2.92M
Enterprise Value
-4.42M
1-Year Change
-0.80%
Global Rank
Country Rank
#6,202 United States
Category
ChartMarket Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.42M to $2.92M, a decrease of -95.68%. That is a compound annual growth rate of -46.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.92M | 140.87% |
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.55% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.63M | -84.67% |
| Dec 31, 2021 | 49.81M | -26.12% |
| Nov 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aethlon Medical | 3.76M |
| IceCure Medical | 3.39M |
| VolitionRx | 3.27M |
| INVO Fertility | 3.10M |
| WORK Medical Technology Group LTD | 2.91M |
| Baird Medical Investment Holdings | 2.90M |
| Autonomix Medical | 2.69M |
| 20/20 Biolabs | 2.61M |